Skip to main content
Clinical Trials/TCTR20180227002
TCTR20180227002
Not yet recruiting
未知

Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) in predicting Chemoradiation Sensitive Nasopharyngeal Carcinoma and Plasma Epstein-Barr virus (EBV) level

none0 sites40 target enrollmentFebruary 27, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
asopharyngeal carcinoma
Sponsor
none
Enrollment
40
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 27, 2018
End Date
February 27, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed patients with pathologically proven of NPC in KCMH
  • Receive chemoradiation therapy as a primary treatment
  • Known pretreatment plasma EBV DNA level

Exclusion Criteria

  • Presence of metastasis
  • Received primary treatment other than chemoradiation
  • Previous chemoradiation therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials